• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·US·Healthcare·CMPD
Share

CompuMed, Inc. Stocks

$ 6.25Last Updated 16.10.2026

Issuer Rating

3/7
Performance

Average

Risk

High

Recommendation

Sell

Market Cap

$ 8.06M

$ 6.25
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Undervalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

CompuMed, Inc. functions as a dedicated provider of advanced telemedicine solutions tailored for organizational clients. The company extends vital clinical care services to both individual patients and various medical facilities internationally. Its primary specializations encompass telecardiology and teleradiology services. These enable healthcare institutions worldwide to connect in real-time with U.S. Board-Certified specialists, utilizing sophisticated cloud-based platforms and integrated medical equipment. Beyond these core areas, CompuMed offers extensive enterprise-level telemedicine frameworks. Its telecardiology portfolio includes a wide array of diagnostic interpretations for adult and pediatric patients, covering examinations such as electrocardiograms (ECG), echocardiograms, vascular studies, holter monitoring, nuclear cardiology assessments, and direct video consultations. In the realm of teleradiology, the company delivers expert image analysis, precise transcription, comprehensive reporting, secure data storage, and video consultations for modalities like Vscan, X-ray, ultrasound, mammography, computed tomography (CT), and magnetic resonance imaging (MRI). CompuMed also offers OsteoGram software, a specialized tool that integrates with both standard and digital X-ray systems to aid in the screening, diagnosis, and ongoing management of osteoporosis. Furthermore, the company supplies mobile ECG and ultrasound solutions, which grant patients direct and immediate access to its network of board-certified medical experts, in addition to providing various medical devices. Its clientele spans a diverse range of sectors, including organ procurement organizations, rural healthcare providers, and correctional healthcare facilities. CompuMed, Inc. was founded in 1973 and is based in Los Angeles, California.

Company Valuation

Undervalued
6/7

Based on key historical and expected multiples, the stock is undervalued relative to its peers. In particular, the stock is of fair value on EV/EBITDA, undervalued on P/F

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

20.10.2026 11:34

The New Energy Boom: How to Profit from the Growth of the Battery Market

20.10.2026 10:49

Morning Highlights: AI Startup's Stock Plummets After IPO; Anthropic and Nscale Deal

20.10.2026 09:54

Revolut has obtained a crypto license in Gibraltar. Why does this neobank need this jurisdiction?

20.10.2026 09:00

Analysts have expressed doubts about demand for the new iPhones. KeyBanc expects Apple's stock to fall 27%.

20.10.2026 08:00

U.S. defense companies fell 16%. Why is the market worried about a Democratic victory in the election?

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026